CLEVELAND-CLIFFS INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CLEVELAND-CLIFFS INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.61B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $19.19B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $22.00B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $22.99B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $20.44B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $5.35B | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | $534.10M | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | $555.60M | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | $743.20M | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | $157.00M | Feb 20, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $126.90M | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | $154.90M | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | $263.00M | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | $30.90M | Feb 20, 2020 |
| FY2019 | Dec 31, 2018 | $202.00M | Feb 20, 2020 |
| FY2019 | Sep 30, 2018 | $261.60M | Feb 20, 2020 |
| FY2019 | Jun 30, 2018 | $284.50M | Feb 20, 2020 |
| FY2019 | Mar 31, 2018 | $61.50M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $116.10M | Feb 8, 2019 |
| FY2018 | Sep 30, 2017 | $157.80M | Feb 8, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.48B) | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | ($760.00M) | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $385.00M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $1.34B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $2.99B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | ($122.00M) | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $293.00M | Feb 11, 2022 |
| FY2018 | Dec 31, 2018 | $609.50M | Feb 8, 2019 |
| FY2018 | Sep 30, 2018 | $437.80M | Feb 8, 2019 |
| FY2018 | Jun 30, 2018 | $165.10M | Feb 8, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.58B) | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | ($763.00M) | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $659.00M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $1.94B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $4.01B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | ($142.00M) | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $429.00M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $673.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $390.20M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $130.70M | Feb 8, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $543.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $486.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $577.00M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $465.00M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $422.00M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $244.00M | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $113.00M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $113.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $102.90M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $115.80M | Feb 8, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($462.00M) | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $105.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $2.27B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $2.42B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $2.79B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | ($258.00M) | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $568.00M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $479.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $338.10M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $303.00M | Feb 8, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $561.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $695.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $646.00M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $943.00M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $705.00M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $525.00M | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $656.00M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $296.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $134.90M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $7.40M | Feb 8, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.01B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $20.95B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $17.54B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $18.76B | Feb 25, 2025 |
| FY2022 | Dec 31, 2021 | $18.98B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $16.77B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $3.50B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $3.53B | Feb 20, 2020 |
| FY2018 | Jan 1, 2018 | $2.99B | Feb 8, 2019 |
| FY2019 | Dec 31, 2017 | $2.95B | Feb 20, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.69B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $14.08B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $9.42B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $10.71B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $13.20B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $13.69B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $3.15B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $3.11B | Feb 20, 2020 |
| FY2018 | Jan 1, 2018 | $3.40B | Feb 8, 2019 |
| FY2018 | Dec 31, 2017 | $3.40B | Feb 8, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.12B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $6.63B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $7.89B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $7.79B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $5.49B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $2.02B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $358.00M | Feb 26, 2021 |
| FY2018 | Dec 31, 2018 | $424.20M | Feb 8, 2019 |
| FY2018 | Jan 1, 2018 | ($410.30M) | Feb 8, 2019 |
| FY2018 | Dec 31, 2017 | ($444.30M) | Feb 8, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.81B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.77B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $1.01B | Feb 9, 2026 |
| FY2023 | Dec 31, 2022 | $1.13B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $1.12B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $1.41B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $2.00M | Feb 26, 2021 |
| FY2015 | Dec 31, 2015 | $2.00M | Feb 24, 2016 |
| FY2015 | Dec 31, 2014 | $2.00M | Feb 24, 2016 |
| FY2015 | Dec 31, 2013 | $74.50M | Feb 24, 2016 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($529.00M) | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $949.00M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $1.73B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.33B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | ($1.00M) | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | ($2.99B) | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | ($2.84B) | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | ($3.06B) | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | ($4.21B) | Feb 8, 2019 |
| FY2017 | Dec 31, 2016 | ($4.57B) | Feb 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $54.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $198.00M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $26.00M | Feb 25, 2025 |
| FY2022 | Dec 31, 2021 | $48.00M | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $112.00M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $353.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $823.20M | Feb 20, 2020 |
| FY2018 | Jan 1, 2018 | $978.30M | Feb 8, 2019 |
| FY2019 | Dec 31, 2017 | $978.30M | Feb 20, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.25B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $7.07B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $3.14B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $4.25B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $5.24B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $5.42B | Feb 11, 2022 |
| FY2018 | Dec 31, 2017 | $2.30B | Feb 8, 2019 |
| FY2017 | Dec 31, 2016 | $2.19B | Feb 14, 2018 |
| FY2016 | Dec 31, 2015 | $2.70B | Feb 9, 2017 |
| FY2015 | Dec 31, 2014 | $2.83B | Feb 24, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 20, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 20, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 569.76M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 493.95M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | 504.89M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | 513.34M | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | 500.16M | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | 477.52M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | 270.08M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 292.61M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | 297.40M | Feb 8, 2019 |
| FY2017 | Dec 31, 2016 | 233.07M | Feb 14, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $0 | Feb 9, 2017 |
| FY2016 | Dec 31, 2015 | $0 | Feb 9, 2017 |
| FY2016 | Dec 31, 2014 | $92.50M | Feb 9, 2017 |
| FY2015 | Dec 31, 2013 | $91.90M | Feb 24, 2016 |
| FY2014 | Dec 31, 2012 | $307.20M | Feb 25, 2015 |
| FY2013 | Dec 31, 2011 | $118.90M | Feb 14, 2014 |
| FY2011 | Dec 31, 2010 | $68.90M | Feb 16, 2012 |
| FY2011 | Dec 31, 2009 | $31.90M | Feb 16, 2012 |
| FY2010 | Dec 31, 2008 | $36.10M | Feb 17, 2011 |
| FY2009 | Dec 31, 2007 | $20.90M | Feb 18, 2010 |